XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 285,531 $ 287,807
Short-term investments 34,252 32,724
Restricted cash 1,100 1,100
Trade accounts receivable (net of $0 allowance at March 31, 2024 and December 31, 2023) 224,084 273,522
Other receivables 10,519 13,700
Inventories 243,690 244,261
Other current assets 63,393 64,653
Total current assets 862,569 917,767
Property, plant and equipment, net 1,235,775 1,228,891
Other assets    
Deferred income taxes 120,792 124,024
Equity investments 24,053 22,815
Fund for asset retirement obligations 144,146 142,266
Other noncurrent assets 47,351 48,410
Total other assets 336,342 337,515
Total assets 2,434,686 2,484,173
Current Liabilities    
Accounts payable 178,119 205,001
Accrued expenses and other current liabilities 113,360 127,617
Current maturities of debt 35,341 35,343
Total current liabilities 326,820 367,961
Long-term debt 107,959 105,252
Asset retirement obligations 260,252 255,740
Accrued pension benefits 861 878
Accrued postretirement benefits other than pension 47,384 47,494
Accrued workers' compensation 155,838 154,650
Other noncurrent liabilities 68,124 72,742
Total liabilities 967,238 1,004,717
Stockholders' equity    
Common stock, $0.01 par value, authorized 300,000 shares, issued 30,785 and 30,557 shares at March 31, 2024 and December 31, 2023, respectively 308 306
Paid-in capital 754,054 720,029
Retained earnings 1,854,621 1,830,018
Treasury stock, 12,607 and 12,197 shares at March 31, 2024 and December 31, 2023, respectively, at cost (1,178,735) (1,109,679)
Accumulated other comprehensive income 37,200 38,782
Total stockholders' equity 1,467,448 1,479,456
Total liabilities and stockholders' equity $ 2,434,686 $ 2,484,173